Johanna G. van der Bom

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study

Samantha C. Gouw, Johanna G. van der Bom, H. Marijke van den Berg · Blood · 2007 · 484 citations

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung et al. · New England Journal of Medicine · 2013 · 431 citations · Full text

Bleeding in carriers of hemophilia

Iris Plug, Eveline P. Mauser‐Bunschoten, Annette Bröcker‐Vriends et al. · Blood · 2006 · 361 citations · Full text

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 319 citations

Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study

Iris Plug, Johanna G. van der Bom, Marjolein Peters et al. · Journal of Thrombosis and Haemostasis · 2006 · 278 citations · Full text

Clinical Epidemiology, Hematology, Bleeding Disorder +3